--- title: "Rapid Molecular Testing Service for Public Health Wales" ocid: "ocds-kuma6s-128781" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-128781" markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-128781.md" json_url: "https://d3tenders.com/contract/ocds-kuma6s-128781.json" source: "Sell2Wales" current_stage: "Planning" buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)" published: "2023-02-02" --- # Rapid Molecular Testing Service for Public Health Wales Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) Current stage: Planning OCID: ocds-kuma6s-128781 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-128781) [Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-128781.json) ## Summary The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is planning a tender for a Rapid Molecular Testing Service for Public Health Wales. The procurement stage is currently at the planning phase, and the user engagement session is scheduled for 27th February 2023 in Cardiff. The service is classified under the health industry category, and the main procurement category is goods. The contract award period is expected to start on 2nd May 2023. This tender presents an opportunity for companies specialising in healthcare diagnostics and rapid testing services to compete. Businesses offering molecular testing solutions tailored to pneumonia, meningoencephalitis, bone and tissue, gastrointestinal, and sexually transmitted syndromes are well-suited to bid. The procurement method involves a written submission, and the contact authority is open to innovative solutions that align with the specified technical criteria. The timely fulfilment of the contract could enhance business growth prospects by demonstrating technological capability and service reliability in the healthcare sector. ## Notice Public Health Wales, in advance of a tender, would like to invite companies to provide their bespoke options for a rapid molecular service based on 2 lots for Wales at a user engagement session on the 27th February 2023 at Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ. -Lot 1 being essential supporting pneumonia and meningoencephalitis syndromic algorithm. -Lot 2 being desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. Interested parties will be offered a user engagement session, further details available from the contracting authority. ### Lot Information Essential supporting pneumonia and meningoencephalitis syndromic algorithm. Essential supporting pneumonia and meningoencephalitis syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines. Desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. Desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Health and Safety during the processing must minimise any potential incident, hazard or risk. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines. * A robust and resilient support post service implementation. ## Key Details | Field | Value | | --- | --- | | Publication source | Sell2Wales | | Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128781 | | Notice type | OJEU - F1 - Prior Information Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 2 Feb 2023 | | Submission deadline | 2 May 2023 | | Future notice date | 6 Mar 2023 | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planned | | Lots status | Planned | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) | | Locality | ST ASAPH | | Post town | Llandudno | | Postcode | LL17 0JL | | Country | Wales | | ITL 1 | TLL Wales | | ITL 2 | TLL3 North Wales | | ITL 3 | TLL33 Conwy and Denbighshire | | Local authority | Denbighshire | | Electoral ward | Bodelwyddan | | Westminster constituency | Clwyd North | | Delivery location | TLL Wales | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33696500 - Laboratory reagents ## Release History - 2 Feb 2023 at 00:00 - Planning - OJEU - F1 - Prior Information Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128781 ## Documents - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=FEB426488 Rapid Molecular Testing Service for Public Health Wales - Public Health Wales, in advance of a tender, would like to invite companies to provide their bespoke options for a rapid molecular service based on 2 lots for Wales at a user engagement session on the 27th February 2023 at Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ. -Lot 1 being essential supporting pneumonia and meningoencephalitis syndromic algorithm. -Lot 2 being desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. Interested parties will be offered a user engagement session, further details available from the contracting authority. ## Notice URLs - http://nwssp.nhs.wales/ourservices/procurement-services/ - https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-128781 ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-128781. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-128781.json.